Reconstruction using the saddle prosthesis following excision of primary and metastatic periacetabular tumors

From 1988 to 1991, 17 patients with malignant periacetabular tumors underwent limb-sparing surgery and reconstruction using the saddle prosthesis. There were 8 patients with primary malignant lesions (Group 1), and 9 patients with metastatic or systemic tumor involving the periacetabular pelvis (Gro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical orthopaedics and related research 1995-05, Vol.314 (314), p.203-213
Hauptverfasser: ABOULAFIA, A. J, BUCH, R, MATHEWS, J, LI, W, MALAWER, M. M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 213
container_issue 314
container_start_page 203
container_title Clinical orthopaedics and related research
container_volume 314
creator ABOULAFIA, A. J
BUCH, R
MATHEWS, J
LI, W
MALAWER, M. M
description From 1988 to 1991, 17 patients with malignant periacetabular tumors underwent limb-sparing surgery and reconstruction using the saddle prosthesis. There were 8 patients with primary malignant lesions (Group 1), and 9 patients with metastatic or systemic tumor involving the periacetabular pelvis (Group 2). All resections included excision of the acetabulum. Patients ranged in age from 24 to 76 years (average, 59.8 years). Local control was achieved in all patients. Wide margins were obtained in all patients with primary pelvic tumors. Functional outcomes were rated as follows excellent (10), good (2), fair (1), and poor (4). Three patients, all of whom had pulmonary metastasis before surgery, died within 8 months of surgery. Of the remaining 14 patients, 5 patients died between 6 and 28 months after the index procedure. At the end of the followup period, 9 patients were still alive (6 in Group 1 and 3 in Group 2), with a followup period ranging from 15 to 62 months (average, 33.4 months). The overall results for surviving patients were 7 excellent and 2 good results, with no fair or poor results.
doi_str_mv 10.1097/00003086-199505000-00027
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77440522</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77440522</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-9fc7717fd294aae9546a6b2a881f210b6bbdad1a78ce6804bcaa209502bf25073</originalsourceid><addsrcrecordid>eNqFUU1LxDAUDKKs6-pPEHIQb9UkbZL2KOIXCIIoeCuvaaKVfqx5Keq_N3XrXg2EMHkzL3kzhFDOzjgr9DmLK2W5SnhRSCYjSuIWeocsuRR5wnkqdsky3hVJIfjLPjlAfJ9EmRQLstAqzVSql6R7tGboMfjRhGbo6YhN_0rDm6UIdd1auvYDRogNUje07fA51e2XaXCiDy4Smg78N4W-pp0NgAFCY-ja-gZMxNXYgqdh7AaPh2TPQYv2aD5X5Pn66unyNrl_uLm7vLhPTKZkSApntOba1aLIAGwhMwWqEpDn3AnOKlVVNdQcdG6syllWGQDBohGickIyna7I6aZv_P3HaDGUXYPGti30dhix1DrLmBTiXyJXeSpFdGtF8g3RRD_QW1fOc5eclVMk5V8k5TaS8jeSKD2e3xirztZb4ZxBrJ_MdUADrfPQR3e3tFSxacb0B-Qdlk0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16835276</pqid></control><display><type>article</type><title>Reconstruction using the saddle prosthesis following excision of primary and metastatic periacetabular tumors</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>ABOULAFIA, A. J ; BUCH, R ; MATHEWS, J ; LI, W ; MALAWER, M. M</creator><creatorcontrib>ABOULAFIA, A. J ; BUCH, R ; MATHEWS, J ; LI, W ; MALAWER, M. M</creatorcontrib><description>From 1988 to 1991, 17 patients with malignant periacetabular tumors underwent limb-sparing surgery and reconstruction using the saddle prosthesis. There were 8 patients with primary malignant lesions (Group 1), and 9 patients with metastatic or systemic tumor involving the periacetabular pelvis (Group 2). All resections included excision of the acetabulum. Patients ranged in age from 24 to 76 years (average, 59.8 years). Local control was achieved in all patients. Wide margins were obtained in all patients with primary pelvic tumors. Functional outcomes were rated as follows excellent (10), good (2), fair (1), and poor (4). Three patients, all of whom had pulmonary metastasis before surgery, died within 8 months of surgery. Of the remaining 14 patients, 5 patients died between 6 and 28 months after the index procedure. At the end of the followup period, 9 patients were still alive (6 in Group 1 and 3 in Group 2), with a followup period ranging from 15 to 62 months (average, 33.4 months). The overall results for surviving patients were 7 excellent and 2 good results, with no fair or poor results.</description><identifier>ISSN: 0009-921X</identifier><identifier>EISSN: 1528-1132</identifier><identifier>DOI: 10.1097/00003086-199505000-00027</identifier><identifier>PMID: 7634637</identifier><identifier>CODEN: CORTBR</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Acetabulum - surgery ; Adult ; Aged ; Biological and medical sciences ; Bone Neoplasms - diagnosis ; Bone Neoplasms - mortality ; Bone Neoplasms - secondary ; Bone Neoplasms - surgery ; Female ; Follow-Up Studies ; Hip Prosthesis - adverse effects ; Hip Prosthesis - instrumentation ; Humans ; Lung Neoplasms - secondary ; Male ; Medical sciences ; Middle Aged ; Neoplasm Staging ; Orthopedic surgery ; Prosthesis Design ; Prosthesis Failure ; Reoperation ; Sarcoma - diagnosis ; Sarcoma - secondary ; Sarcoma - therapy ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Survival Rate ; Treatment Outcome</subject><ispartof>Clinical orthopaedics and related research, 1995-05, Vol.314 (314), p.203-213</ispartof><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-9fc7717fd294aae9546a6b2a881f210b6bbdad1a78ce6804bcaa209502bf25073</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3606804$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7634637$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ABOULAFIA, A. J</creatorcontrib><creatorcontrib>BUCH, R</creatorcontrib><creatorcontrib>MATHEWS, J</creatorcontrib><creatorcontrib>LI, W</creatorcontrib><creatorcontrib>MALAWER, M. M</creatorcontrib><title>Reconstruction using the saddle prosthesis following excision of primary and metastatic periacetabular tumors</title><title>Clinical orthopaedics and related research</title><addtitle>Clin Orthop Relat Res</addtitle><description>From 1988 to 1991, 17 patients with malignant periacetabular tumors underwent limb-sparing surgery and reconstruction using the saddle prosthesis. There were 8 patients with primary malignant lesions (Group 1), and 9 patients with metastatic or systemic tumor involving the periacetabular pelvis (Group 2). All resections included excision of the acetabulum. Patients ranged in age from 24 to 76 years (average, 59.8 years). Local control was achieved in all patients. Wide margins were obtained in all patients with primary pelvic tumors. Functional outcomes were rated as follows excellent (10), good (2), fair (1), and poor (4). Three patients, all of whom had pulmonary metastasis before surgery, died within 8 months of surgery. Of the remaining 14 patients, 5 patients died between 6 and 28 months after the index procedure. At the end of the followup period, 9 patients were still alive (6 in Group 1 and 3 in Group 2), with a followup period ranging from 15 to 62 months (average, 33.4 months). The overall results for surviving patients were 7 excellent and 2 good results, with no fair or poor results.</description><subject>Acetabulum - surgery</subject><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Bone Neoplasms - diagnosis</subject><subject>Bone Neoplasms - mortality</subject><subject>Bone Neoplasms - secondary</subject><subject>Bone Neoplasms - surgery</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Hip Prosthesis - adverse effects</subject><subject>Hip Prosthesis - instrumentation</subject><subject>Humans</subject><subject>Lung Neoplasms - secondary</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Orthopedic surgery</subject><subject>Prosthesis Design</subject><subject>Prosthesis Failure</subject><subject>Reoperation</subject><subject>Sarcoma - diagnosis</subject><subject>Sarcoma - secondary</subject><subject>Sarcoma - therapy</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><issn>0009-921X</issn><issn>1528-1132</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUU1LxDAUDKKs6-pPEHIQb9UkbZL2KOIXCIIoeCuvaaKVfqx5Keq_N3XrXg2EMHkzL3kzhFDOzjgr9DmLK2W5SnhRSCYjSuIWeocsuRR5wnkqdsky3hVJIfjLPjlAfJ9EmRQLstAqzVSql6R7tGboMfjRhGbo6YhN_0rDm6UIdd1auvYDRogNUje07fA51e2XaXCiDy4Smg78N4W-pp0NgAFCY-ja-gZMxNXYgqdh7AaPh2TPQYv2aD5X5Pn66unyNrl_uLm7vLhPTKZkSApntOba1aLIAGwhMwWqEpDn3AnOKlVVNdQcdG6syllWGQDBohGickIyna7I6aZv_P3HaDGUXYPGti30dhix1DrLmBTiXyJXeSpFdGtF8g3RRD_QW1fOc5eclVMk5V8k5TaS8jeSKD2e3xirztZb4ZxBrJ_MdUADrfPQR3e3tFSxacb0B-Qdlk0</recordid><startdate>19950501</startdate><enddate>19950501</enddate><creator>ABOULAFIA, A. J</creator><creator>BUCH, R</creator><creator>MATHEWS, J</creator><creator>LI, W</creator><creator>MALAWER, M. M</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7X8</scope></search><sort><creationdate>19950501</creationdate><title>Reconstruction using the saddle prosthesis following excision of primary and metastatic periacetabular tumors</title><author>ABOULAFIA, A. J ; BUCH, R ; MATHEWS, J ; LI, W ; MALAWER, M. M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-9fc7717fd294aae9546a6b2a881f210b6bbdad1a78ce6804bcaa209502bf25073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Acetabulum - surgery</topic><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Bone Neoplasms - diagnosis</topic><topic>Bone Neoplasms - mortality</topic><topic>Bone Neoplasms - secondary</topic><topic>Bone Neoplasms - surgery</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Hip Prosthesis - adverse effects</topic><topic>Hip Prosthesis - instrumentation</topic><topic>Humans</topic><topic>Lung Neoplasms - secondary</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Orthopedic surgery</topic><topic>Prosthesis Design</topic><topic>Prosthesis Failure</topic><topic>Reoperation</topic><topic>Sarcoma - diagnosis</topic><topic>Sarcoma - secondary</topic><topic>Sarcoma - therapy</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ABOULAFIA, A. J</creatorcontrib><creatorcontrib>BUCH, R</creatorcontrib><creatorcontrib>MATHEWS, J</creatorcontrib><creatorcontrib>LI, W</creatorcontrib><creatorcontrib>MALAWER, M. M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical orthopaedics and related research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ABOULAFIA, A. J</au><au>BUCH, R</au><au>MATHEWS, J</au><au>LI, W</au><au>MALAWER, M. M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reconstruction using the saddle prosthesis following excision of primary and metastatic periacetabular tumors</atitle><jtitle>Clinical orthopaedics and related research</jtitle><addtitle>Clin Orthop Relat Res</addtitle><date>1995-05-01</date><risdate>1995</risdate><volume>314</volume><issue>314</issue><spage>203</spage><epage>213</epage><pages>203-213</pages><issn>0009-921X</issn><eissn>1528-1132</eissn><coden>CORTBR</coden><abstract>From 1988 to 1991, 17 patients with malignant periacetabular tumors underwent limb-sparing surgery and reconstruction using the saddle prosthesis. There were 8 patients with primary malignant lesions (Group 1), and 9 patients with metastatic or systemic tumor involving the periacetabular pelvis (Group 2). All resections included excision of the acetabulum. Patients ranged in age from 24 to 76 years (average, 59.8 years). Local control was achieved in all patients. Wide margins were obtained in all patients with primary pelvic tumors. Functional outcomes were rated as follows excellent (10), good (2), fair (1), and poor (4). Three patients, all of whom had pulmonary metastasis before surgery, died within 8 months of surgery. Of the remaining 14 patients, 5 patients died between 6 and 28 months after the index procedure. At the end of the followup period, 9 patients were still alive (6 in Group 1 and 3 in Group 2), with a followup period ranging from 15 to 62 months (average, 33.4 months). The overall results for surviving patients were 7 excellent and 2 good results, with no fair or poor results.</abstract><cop>Heidelberg</cop><pub>Springer</pub><pmid>7634637</pmid><doi>10.1097/00003086-199505000-00027</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-921X
ispartof Clinical orthopaedics and related research, 1995-05, Vol.314 (314), p.203-213
issn 0009-921X
1528-1132
language eng
recordid cdi_proquest_miscellaneous_77440522
source MEDLINE; Journals@Ovid Complete
subjects Acetabulum - surgery
Adult
Aged
Biological and medical sciences
Bone Neoplasms - diagnosis
Bone Neoplasms - mortality
Bone Neoplasms - secondary
Bone Neoplasms - surgery
Female
Follow-Up Studies
Hip Prosthesis - adverse effects
Hip Prosthesis - instrumentation
Humans
Lung Neoplasms - secondary
Male
Medical sciences
Middle Aged
Neoplasm Staging
Orthopedic surgery
Prosthesis Design
Prosthesis Failure
Reoperation
Sarcoma - diagnosis
Sarcoma - secondary
Sarcoma - therapy
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Survival Rate
Treatment Outcome
title Reconstruction using the saddle prosthesis following excision of primary and metastatic periacetabular tumors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T21%3A00%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reconstruction%20using%20the%20saddle%20prosthesis%20following%20excision%20of%20primary%20and%20metastatic%20periacetabular%20tumors&rft.jtitle=Clinical%20orthopaedics%20and%20related%20research&rft.au=ABOULAFIA,%20A.%20J&rft.date=1995-05-01&rft.volume=314&rft.issue=314&rft.spage=203&rft.epage=213&rft.pages=203-213&rft.issn=0009-921X&rft.eissn=1528-1132&rft.coden=CORTBR&rft_id=info:doi/10.1097/00003086-199505000-00027&rft_dat=%3Cproquest_cross%3E77440522%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16835276&rft_id=info:pmid/7634637&rfr_iscdi=true